UPDATE 1-FDA puts partial hold on clinical trials of AbbVie's cancer drug
March 19, 2019 at 09:36 AM EDT
AbbVie Inc said on Tuesday the U.S. Food and Drug Administration placed a partial clinical hold on all trials of its cancer drug Venclexta for multiple myeloma, after a review of data found a higher proportion of deaths in the Venclexta arm of the late-stage study.